Analysis of bone alkaline phosphatase as a marker for the diagnosis of osteoporosis in men under androgen ablation

International Journal of Biological Markers

Volumn 18, Issue 4, 2003, Pages 290-294

  Morote, Juan ^a   Trilla, E ^a   Esquena, S ^a   Abascal, J M ^a   Segura, R M ^a   Catalan, R ^a   Encabo, G ^a   Reventos J ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Androgen ablation; Bone alkaline phosphatase; Osteoporosis; Prostate cancer

Indexed keywords

ALKALINE PHOSPHATASE; ANDROGEN; BIOLOGICAL MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITOMETRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; HIP FRACTURE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; OSTEOPENIA; OSTEOPOROSIS; PREDICTION; PROSTATE CANCER; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 1242342153     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.1583     Document Type: Article

References (20)

1. Seeman E, Melton LT III, O'Fallon WM, et al. Risk factors for spinal osteoporosis in men. Am J Med 1983; 75: 977-83.
2. Kelepouris N, Harper KD, Gannon F, Kaplan FS, Haddad JG. Severe osteoporosis in men. Ann Int Med 1995; 123: 452-60.
3. Jackson JA, Riggs MW, Spiekerman AM. Testosterone deficiency as a risk factor for hip fractures in men. Am J Med Sci 1992; 304: 4-8.
4. Baillie SP, Davison CE, Johnson FJ, Francis RM. Pathogenesis of vertebral crush fractures in men. Age Aging 1992; 21: 139-8.
5. Stanley HL, Schmith BP, Poses RM, Deiss WP. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc 1991; 39: 766-71.
6. Genant HK, Engelke K, Fuert T, et al. Non invasive assessment of bone mineral and structure: state of the art. J Bone Miner Res 1996; 11: 707-25.
7. Marcus R, Holloway L, Wells B, et al. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal estrogen/progestin interventions (PEPI) trial. J Bone Miner Res 1999; 14: 1583-95.
8. Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG. Osteopenia in insulin-dependent diabetes mellitus, prevalence and aspects of pathophysiology. J Endocrinol Invest 2000; 23: 295-303.
9. Vestergaard P, Hermann AP, Gram J, et al. Evaluation of methods for the prediction of bone mineral density by clinical and biochemical variables in perimenopausal women. Maturitas 2001; 40: 211-20.
10. Majkic-Singh N, Ilic M, Ignjatovic S, Postic-Grujin A. Assessment of four biochemical markers of bone metabolism in postmenopausal osteoporosis. Clin Lab 2002; 48: 407-13.
11. Maimoun L, Couret I, Micallef JP, et al. Use of bone biochemical markers with dual-energy x-ray absorptiometry for early determination of bone loss in persons with spinal cord injury. Metabolism 2002; 51: 958-63.
12. Scopacasa F, Wishart JM, Need AG, Horowitz M, Morris HA, Nordin BE. Bone density and bone-related biochemical variables in normal men: a longitudinal study. J Gerontol A Biol Sci Med 2002; 57: 385-91.
13. Delmas PD, Herdy P, Garnero P, Dain M. Monitoring individual response to hormone replacement therapy with bone markers. Bone 2000; 26: 553-60.
14. Rossini M, Gatti D, Girardello S, Braga V, James G, Adami S. Effects of two intermittent alendronate regimens in the prevention or treatment of postmenopausal osteoporosis. Bone 2000; 27: 119-22.
15. Rittmaster R, Bolognese M, Ettinger MP, et al. Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate. J Clin Endocrinol Metab 2000; 85: 2119-34.
16. Ross PD, Kree BC, Parson RE, et al. Serum bone alkaline phosphatase and calcaneus bone mineral density predict fractures: a prospective study. Osteoporosis Int 2000; 11: 76-82.
17. Morote J, Id H'Mammed Y, Martínez E, Esquena S, Lorente JA, Gelabert A. Increases of bone alkaline phosphatase after androgen deprivation therapy in patients with prostate cancer. Urology 2002; 59: 277-80.
18. Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of hip fractures. Lancet 1993; 341: 72-5.
19. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group. Geneva: WHO, 1994.
20. Reddi AH, Huggins CB. Citrate and alkaline phosphatase during transformation of fibroblasts by the matrix and minerals of bone. Proc Soc Exp Biol Med 1972; 140: 807-10.